Integrated Proteins re-designates Hiren Shah as CMD for five-year term

2 min read     Updated on 24 Jul 2026, 10:01 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Integrated Proteins Ltd approved the re-designation of Hiren Dhirajlal Shah as Chairman and Managing Director for a five-year term starting July 24, 2026. The move requires shareholder approval at an EGM on August 20, 2026. Shah, previously Additional Executive Director, holds degrees in BCA and LL.B. and has extensive experience in finance and compliance. The appointment follows SEBI Listing Regulations and Companies Act provisions.

powered bylight_fuzz_icon
46456267

*this image is generated using AI for illustrative purposes only.

Integrated Proteins has moved to consolidate its leadership structure by approving the re-designation of Hiren Dhirajlal Shah as Chairman and Managing Director (CMD). The Board of Directors sanctioned the change during a meeting held on July 24, 2026, at the company’s registered office in Jamnagar, Gujarat. This strategic shift elevates Shah from his previous role as Additional Executive Director, signaling a focused approach to corporate governance and executive oversight for the listed protein products manufacturer.

The appointment is subject to ratification by shareholders at an Extra-Ordinary General Meeting (EGM). The Board has scheduled the EGM for August 20, 2026, to be conducted via Video Conferencing or Other Audio Visual Means (OAVM). Shareholders holding shares as of the cut-off date of August 13, 2026, will be eligible to vote. The e-voting window opens on August 17, 2026, at 9:00 AM and closes on August 19, 2026, at 5:00 PM. Mrs. Ankita Tejas Shah, a Practicing Company Secretary, has been appointed as the scrutinizer for the e-voting process.

Shah’s tenure as CMD will span five years, commencing on July 24, 2026, and concluding on July 23, 2031. The Board’s decision aligns with Sections 196, 197, and 203 of the Companies Act, 2013, read with Schedule V, and the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014. The filing confirms that Shah is not debarred from holding directorial office by the Securities and Exchange Board of India (SEBI) or any other regulatory authority.

The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and SEBI Master Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated January 30, 2026. The company filed the details with BSE Limited, where it is listed under Scrip Code 519606.

Key Details of the Appointment

Particulars Details
Appointee Hiren Dhirajlal Shah
New Designation Chairman and Managing Director
Previous Role Additional Executive Director
DIN 09842161
Tenure Start Date July 24, 2026
Tenure End Date July 23, 2031
Shareholder Approval Required at EGM

Leadership Profile

Hiren Dhirajlal Shah brings a multidisciplinary background to the top leadership role. He holds a Bachelor of Computer Applications (BCA) and a Bachelor of Laws (LL.B.) degree from Saurashtra University. His professional expertise spans finance, accounting, business administration, and corporate management. Over the years, Shah has been actively involved in financial planning, regulatory compliance, and strategic decision-making, providing Integrated Proteins with experienced oversight in both operational and legal domains. The Board noted no relationship disclosures between directors regarding this appointment.

Historical Stock Returns for Integrated Proteins

1 Day5 Days1 Month6 Months1 Year5 Years
+1.77%-1.51%-4.30%+372.04%+210.74%+4,120.59%

How might Hiren Dhirajlal Shah's combined legal and financial background influence Integrated Proteins' strategy for navigating upcoming regulatory changes in the protein manufacturing sector?

What specific operational or strategic initiatives is the board expected to prioritize under Shah's five-year tenure as CMD to drive revenue growth?

Could this leadership consolidation signal a shift in corporate governance that aims to improve investor confidence and stabilize stock performance on the BSE?

Integrated Proteins seeks BSE nod to reclassify promoters

2 min read     Updated on 14 Jul 2026, 02:18 PM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Integrated Proteins Ltd has applied to BSE Ltd to reclassify ten shareholders from the 'Promoter & Promoter Group' category to the 'Public' category, covering 4,17,620 equity shares or 2.23% of paid-up capital. The requests, dated July 7, 2026, were made under Regulation 31A of SEBI LODR Regulations, with applicants confirming no control over company affairs. The reclassification is subject to BSE approval and compliance with conditions for three years.

powered bylight_fuzz_icon
45056909

*this image is generated using AI for illustrative purposes only.

Integrated Proteins Ltd has applied to BSE Ltd for a no-objection certificate to reclassify ten shareholders from the 'Promoter & Promoter Group' category to the 'Public' category. The application, submitted on July 14, 2026, follows requests received from the shareholders on July 7, 2026, under Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The reclassification covers a total of 4,17,620 equity shares, representing 2.23% of the company's total paid-up share capital, and aims to align the status of these shareholders with their current lack of involvement in the company's affairs.

The applicants provided undertakings confirming they do not hold more than 10% of the total voting rights, do not exercise control over the company's affairs, and have no special rights through formal or informal arrangements. They also affirmed they are not wilful defaulters or fugitive economic offenders. The Board of Directors noted that outgoing promoters, except Vinod Prabhulal Mehta, have no representation on the Board and are not involved in day-to-day affairs. The reclassification is contingent upon the applicants complying with conditions specified in Regulation 31A(3)(b) for a period of not less than three years from the date of reclassification.

Shareholding Details

The following table details the shareholding of the applicants seeking reclassification:

Name Category Shares Held % of Shares Held
Vinod Prabhulal Mehta Promoter 3,22,300 1.72
Amrish Vinod Mehta Promoter Group 53,300 0.28
Jyoti Vinodchandra Mehta Promoter Group 30,500 0.16
Piyush Chimanlal Vora Promoter 10,010 0.05
Purnimaben Piyushbhai Vora Promoter Group 1,510 0.01
Arvindbhai Kantilal Shah Promoter Group 0 0.00
Chintan Arvindbhai Shah Promoter Group 0 0.00
Parul Shah Promoter Group 0 0.00
Ranjanben Upendra Dholakia Promoter Group 0 0.00
Vinit Arvind Shah Promoter Group 0 0.00
Total 4,17,620 2.23

The company confirmed that it is compliant with the minimum public shareholding requirements under Regulation 22 of SEBI LODR Regulations and has no outstanding dues to SEBI, stock exchanges, or depositories. The reclassification will be effected in the shareholding pattern filed for the immediate succeeding quarter upon receiving all necessary approvals.

Historical Stock Returns for Integrated Proteins

1 Day5 Days1 Month6 Months1 Year5 Years
+1.77%-1.51%-4.30%+372.04%+210.74%+4,120.59%

How will the reduction in promoter holding influence Integrated Proteins Ltd's corporate governance strategy and future board composition?

Could this reclassification trigger a reassessment of the company's valuation by institutional investors due to the increased free float?

What impact will the exit of these shareholders have on the company's ability to raise capital or secure strategic partnerships in the future?

More News on Integrated Proteins

1 Year Returns:+210.74%